Literature DB >> 10864147

Characterization of histamine release induced by fluoroquinolone antibacterial agents in-vivo and in-vitro.

K Mori1, C Maru, K Takasuna.   

Abstract

Characterization of histamine release induced by fluoroquinolone antibacterial agents, levofloxacin and ciprofloxacin, was investigated in-vivo and in-vitro. Intravenous injection of levofloxacin and ciprofloxacin at 1-10 mg kg(-1) produced dose-related elevations in plasma histamine level in anaesthetized dogs. In contrast, levofloxacin was devoid of plasma histamine increment in anaesthetized rats at 100 mg kg(-1), whereas ciprofloxacin at the same dose caused endogenous histamine release. Levofloxacin and ciprofloxacin induced non-cytotoxic secretion of histamine from all mast cells tested in a concentration-dependent manner, whereas rat skin and peritoneal mast cells were thirty- to one-hundred-times less sensitive to the effect of fluoroquinolones as compared with the canine skin mast cells. These results suggest that the functional heterogeneity of mast cells from different species in histamine releasing activity of fluoroquinolones may exist, and that mast cells from the dog appear to be particularly sensitive to the effect of the fluoroquinolones.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10864147     DOI: 10.1211/0022357001774228

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  8 in total

Review 1.  Antimicrobial stewardship's new weapon? A review of antibiotic allergy and pathways to 'de-labeling'.

Authors:  Jason Trubiano; Elizabeth Phillips
Journal:  Curr Opin Infect Dis       Date:  2013-12       Impact factor: 4.915

2.  Ligands and Signaling of Mas-Related G Protein-Coupled Receptor-X2 in Mast Cell Activation.

Authors:  Yan-Ni Mi; Na-Na Ping; Yong-Xiao Cao
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

Review 3.  Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases.

Authors:  Hariharan Subramanian; Kshitij Gupta; Hydar Ali
Journal:  J Allergy Clin Immunol       Date:  2016-07-20       Impact factor: 10.793

4.  Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions.

Authors:  Benjamin D McNeil; Priyanka Pundir; Sonya Meeker; Liang Han; Bradley J Undem; Marianna Kulka; Xinzhong Dong
Journal:  Nature       Date:  2014-12-17       Impact factor: 49.962

5.  Novel phenotype in beagle dogs characterized by skin response to compound 48/80 focusing on skin mast cell degranulation.

Authors:  Mitsuhiro Uchida; Fumi Ito; Toshiyuki Tsuchiya; Yoko Shoji; Toru Kurosawa
Journal:  Exp Anim       Date:  2015-06-09

Review 6.  Therapeutic Potential of MRGPRX2 Inhibitors on Mast Cells.

Authors:  Hiroyuki Ogasawara; Masato Noguchi
Journal:  Cells       Date:  2021-10-27       Impact factor: 6.600

7.  Determination of key residues in MRGPRX2 to enhance pseudo-allergic reactions induced by fluoroquinolones.

Authors:  Eri Hamamura-Yasuno; Junya Matsushita; Seiji Sato; Takashi Shimada; Yoshimi Tsuchiya; Kazunori Fujimoto; Kazuhiko Mori
Journal:  Sci Rep       Date:  2022-04-22       Impact factor: 4.996

8.  Identification of the dog orthologue of human MAS-related G protein coupled receptor X2 (MRGPRX2) essential for drug-induced pseudo-allergic reactions.

Authors:  Eri Hamamura-Yasuno; Takuma Iguchi; Kazuyoshi Kumagai; Yoshimi Tsuchiya; Kazuhiko Mori
Journal:  Sci Rep       Date:  2020-09-30       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.